108,803,656 133,755,071 (24,951,415) (18.66) Net Profit (Loss) (72,320,514) (72,280,526) (39,988) (0.06) Earnings per share (Baht per share) (0.015) (0.016) 0.001 6.25 Net Profit (Loss) The Company and
) 84.18 116.40 Earnings per share (Baht per share) (0.030) (0.015) 0.0149 99.40 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of 156.50 million Baht in 2019, and net loss
) (11.18) Net Profit (Loss) (43.62) (6.22) 37.40 601.29 Earnings per share (Baht per share) (0.008) (0.001) 0.007 700.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of
412.16% Earnings per share (Baht per share) 0.0934 (0.0299) 0.1233 412.16% Net Profit (Loss) After adjusted EBITDA 608.81 11.04% (61.96) (3.13%) 670.76 1,082.66% ท่ีตั้ง 55/2 หมู ่8 ถ. เศรษฐกิจ 1 ต.คลองมะ
quarter and some of the large project in 2021. In addition, the Company was less impacted by the COVID-19 situation in Q1–2021 than those in Q1–2020. Many customers in that period had postponed the delivery
revenues from sales and services from distributor of medical devices and equipment at the 3Q/2017 was 87 million compared to the 2Q/2017. This is because medical devices have been delivery since end of 2Q
expenses 115.49 106.14 9.35 8.8% Total expenses 3,065.73 3,066.16 -0.43 0.0% Earning before interest and tax 253.50 341.41 -87.91 -25.8% Finance cost -5.55 -4.83 -0.72 14.9% Share of profit from investment
compared to the 2Q/2018. This is because medical devices have been delivery since end of 2Q/2018 and complete in 3Q/2018. Revenues from sales and services from distributor of medical devices and equipment at